All Articles

A former oil refinery is being transformed into the Northeast's largest film studio, a $1B project poised to make New Jersey a new Hollywood East.

Glucotrack seeks FDA trial approval for its revolutionary 3-year implantable glucose monitor, racing against financial clocks to change diabetes care.

Amid major Medicare policy shifts, Nuo Therapeutics reports a 169% revenue surge, positioning its Aurix wound care system as a key market disruptor.

A new study finds a minimally invasive procedure provides greater short-term weight loss than a popular pill, reshaping the debate on obesity treatment.

The iconic American rib chain is back in China, but this is more than just a restaurant opening. It's a high-tech, high-stakes bet on the future.

Nubank's AI-first strategy drives record revenue and profitability in Mexico, but rising delinquencies test its advanced risk management models.

A Houston firm is set to make waves with a rare Modigliani drawing and a private Dalí painting, complete with personal letters from the artist.

The federal push for electrification faces backlash for ignoring propane's key role in rural and Northern Canada, raising fears of a costly transition.

As its CFO presents at a top NYC conference, Healios K.K. advances novel stem cell treatments for ARDS, stroke, and cancer into critical global trials.

Westaim posted a $33.4M Q1 loss, but strong early sales from its new annuity product suggest a long-term strategic transformation is taking root.

A new partnership with China's Xiaohongshu signals a major shift, as Singapore moves to attract travelers driven by niche interests and social media trends.

The Solana treasury firm reported a massive GAAP loss due to SOL's price drop, but it also secured new debt, bought back shares, and pushed into new markets.

An OPP constable faces a manslaughter charge from the SIU after a fatal 2025 shooting, igniting a debate on police accountability and union allegiance.

Out of 600+ plans, Alignment Health is one of just four to earn a top award for medication quality. Here's what that means for seniors and the industry.

A new facility in Elmira, NY, is converting harmful landfill emissions into clean energy, powering homes and reducing carbon output by 47,000 tons annually.

Figma's revenue growth accelerated to 46% in Q1, driven by the successful monetization of its AI tools and deepening enterprise adoption.

Boston Omaha posts higher revenue and operational cash flow, but a wider net loss driven by investment headwinds reveals a complex picture for investors.

Edesa Biotech pushes its pipeline forward with a new vitiligo trial and promising ARDS data, but rising R&D costs highlight the high stakes of innovation.

The chip equipment giant posts record Q2 revenue and profit, driven by surging AI demand, and unveils major partnerships to accelerate future tech.

The biotech firm is set to launch its first commercial products, using an innovative strategy to tackle long-neglected markets in women's healthcare.